XOOMAR

Vivos Therapeutics (VVOS)

Vivos Therapeutics on one page: short interest, daily short volume, fails to deliver, large holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

2.9M

Short interest

settlement 2026-09-30

1.0

Days to cover

unchanged vs prior

31.5%

Short share of volume

2026-10-23

570,147

Fails to deliver

settlement 2026-09-30

Wed 18 Nov

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-10-23.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 30 September 2026, short interest in VVOS is 2,864,201 shares, up 360,722 shares over the last month. Over the last 48 readings it ranged from 69,756 shares (15 October 2024) to 2,864,201 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 8.0M shares a day that is 1.0 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/vvos" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-09-302,864,201+76.1%8,031,0921.00
2026-09-151,626,351-35.0%9,032,0331.00
2026-08-312,503,479+100.4%49,532,7771.00
2026-08-141,249,260+4.0%5,552,2191.00
2026-07-311,201,767-0.2%154,1847.79
2026-07-151,203,866+2.5%195,3156.16
2026-06-301,174,295+23.9%1,685,1171.00
2026-06-15947,441+20.4%7,024,2921.00
2026-05-29786,598-19.6%160,2384.91
2026-05-15978,065+36.6%151,8026.44
2026-04-30716,108+29.3%344,5952.08
2026-04-15554,017+75.3%434,6871.27
2026-03-31316,118-34.7%118,9132.66
2026-03-13484,373+1.1%113,4564.27
2026-02-27478,895+3.0%71,4426.70
2026-02-13465,161+0.6%129,4643.59
2026-01-30462,619+11.2%145,9953.17
2026-01-15415,924+47.4%161,8602.57
2025-12-31282,105-2.8%96,8282.91
2025-12-15290,087-4.5%133,7202.17
2025-11-28303,793-3.6%126,7682.40
2025-11-14315,028+4.1%115,3012.73
2025-10-31302,560+3.5%261,5531.16
2025-10-15292,381-49.6%243,3741.20
2025-09-30579,802+122.8%741,7621.00
2025-09-15260,244+34.0%101,2642.57
2025-08-29194,286-26.6%157,8041.23
2025-08-15264,649+5.1%204,9991.29
2025-07-31251,822-18.9%191,8781.31
2025-07-15310,373-34.5%3,652,4391.00
2025-06-30473,906+54.3%350,7611.35
2025-06-13307,230+0.6%120,5432.55
2025-05-30305,495+48.3%174,1561.75
2025-05-15205,993-20.6%74,4342.77
2025-04-30259,397+17.6%84,9903.05
2025-04-15220,591-23.3%94,1622.34
2025-03-31287,716+15.5%66,7414.31
2025-03-14249,020-27.6%90,6772.75
2025-02-28344,021+22.1%269,2641.28
2025-02-14281,727+0.1%120,8002.33
2025-01-31281,444+3.1%292,6211.00
2025-01-15272,993+134.9%332,1721.00
2024-12-31116,219-21.5%291,8261.00
2024-12-13148,038+28.9%219,3611.00
2024-11-29114,838-12.2%174,2591.00
2024-11-15130,752+37.5%183,6781.00
2024-10-3195,088+36.3%142,0461.00
2024-10-1569,756-25.5%139,2771.00

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 23 October 2026, the short share of VVOS volume is 31.5%, down 2.6 points over the last five sessions. Over the last 30 readings it ranged from 15.4% (21 October 2026) to 71.9% (12 October 2026). The latest reading is 14.1 points below the 30-session average of 45.6%, on 246K shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-10-2378K246K31.5%0
2026-10-22270K788K34.2%0
2026-10-21247K1.6M15.4%1,200
2026-10-202.5M6.9M36.9%107,289
2026-10-19329K829K39.6%137,099
2026-10-16353K1.0M34.1%15,820
2026-10-153.1M5.2M58.9%78,217
2026-10-14218K415K52.5%0
2026-10-13217K487K44.5%0
2026-10-12136K189K71.9%27
2026-10-09514K989K52.0%22,541
2026-10-08316K467K67.6%25,024
2026-10-07162K231K70.3%0
2026-10-06127K285K44.6%18,782
2026-10-05113K360K31.4%4,659
2026-10-02147K414K35.5%14,075
2026-10-01277K763K36.2%27,986
2026-09-30218K1.2M18.7%62,004
2026-09-294.7M12.5M37.7%540,342
2026-09-28462K824K56.1%1,571
2026-09-25183K325K56.2%34,283
2026-09-24354K527K67.1%24,268
2026-09-23538K927K58.0%94,517
2026-09-22258K614K42.0%3,610
2026-09-21218K390K56.0%20,207
2026-09-18528K1.0M51.6%24,879
2026-09-17442K907K48.8%12,594
2026-09-16483K813K59.4%71,695
2026-09-15213K931K22.9%4,924
2026-09-14192K534K35.9%0

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 30 September 2026, the fails-to-deliver balance in VVOS is 570,147 shares, up 510,550 shares over the last settlement date. Over the last 30 readings it ranged from 34 shares (23 September 2026) to 11,976,326 shares (1 September 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-09-30570,147$0.15$86K
2026-09-2859,597$0.14$8K
2026-09-2524,501$0.15$4K
2026-09-24116,664$0.15$17K
2026-09-2334$0.16$5
2026-09-2221,980$0.16$4K
2026-09-1840,220$0.18$7K
2026-09-148,229$0.18$1K
2026-09-10354$0.17$60
2026-09-093,329$0.18$599
2026-09-082,245$0.19$427
2026-09-03138,153$0.17$23K
2026-09-02410,370$0.17$70K
2026-09-0111,976,326$0.20$2.4M
2026-08-3175,983$0.22$17K
2026-08-284,836$0.26$1K
2026-08-27269,920$0.25$67K
2026-08-2611,879$0.27$3K
2026-08-2545$0.28$13
2026-08-242,217$0.30$665
2026-08-2138$0.28$11
2026-08-2029,497$0.28$8K
2026-08-1732,778$0.34$11K
2026-08-1267,244$0.31$21K
2026-08-075,614$0.32$2K
2026-08-0697$0.34$33
2026-08-05379,124$0.46$174K
2026-07-314,800$0.41$2K
2026-07-293,571$0.42$1K
2026-07-241,454$0.39$567

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for VVOS in the last 90 days. The most recent filings are listed below. Latest filing: Amman Bradford K. (Principal Accounting Officer) on 2026-07-31.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-07-31Amman Bradford K.Principal Accounting OfficerGrant250K$0.41$103K250K
2026-06-30Huntsman Ronald KirkChief Executive OfficerOther transaction86K$0.58$50K86K
2026-03-31V-Co Investors 3 LLCTenPercentOwnerBuy1.0M$1.34$1.4M1.0M
2026-03-31V-Co Investors 3 LLCTenPercentOwnerBuy309K$1.34$414K1.4M
2026-03-31Skaff Michael C10% ownerBuy309K$1.34$414K1.4M
2026-03-31Skaff Michael C10% ownerBuy1.0M$1.34$1.4M1.0M
2023-06-20Huntsman Ronald KirkChief Executive OfficerBuy14K$0.53$7K87K
2023-06-16Huntsman Ronald KirkChief Executive OfficerBuy10K$0.54$5K68K
2023-06-16Huntsman Ronald KirkChief Executive OfficerBuy5K$0.53$3K73K
2023-06-15Huntsman Ronald KirkChief Executive OfficerBuy21$0.50$1158K
2023-06-14Huntsman Ronald KirkChief Executive OfficerBuy10K$0.49$5K58K
2022-12-23Huntsman Ronald KirkChief Executive OfficerBuy20K$0.50$10K48K
2022-06-01Huntsman Ronald KirkChief Executive OfficerBuy4K$1.83$7K28K
2022-05-31Huntsman Ronald KirkChief Executive OfficerBuy8K$2.03$16K24K
2021-09-21Huntsman Ronald KirkChief Executive OfficerBuy5K$4.31$22K16K
2021-08-17Huntsman Ronald KirkChief Executive OfficerBuy5K$3.00$15K11K
2021-05-25Huntsman Ronald KirkChief Executive OfficerBuy4K$5.38$22K6K
2021-05-25Amman Bradford K.Chief Financial OfficerBuy1K$5.29$5K2K
2020-12-24Amman Bradford K.Chief Financial OfficerBuy1K$7.38$7K1K
2020-12-23UnknownChief Executive OfficerBuy1K$7.27$7K2K
2020-12-11Huntsman Ronald KirkChief Executive OfficerBuy500$8.50$4K500

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

4 holders report 5% or more of VVOS in their latest filing, all on Schedule 13D (active intent). The largest reported stake is Michael C. Skaff at 19.9% of the class (2,783,102 shares), filed 2026-07-15 for an event on 2026-06-30.

FiledFormHolderSharesOf classEvent
2026-09-0313G/Ano. 1Streeterville Capital LLCother entity123K0.6%2026-09-03
2026-09-0313G/Ano. 1Streeterville Management, LLCother entity123K0.6%2026-09-03
2026-09-0313G/Ano. 1John M Fifeindividual123K0.6%2026-09-03
2026-08-1413G/Ano. 1Armistice Capital, LLCinvestment adviser, other entity730K5.0%2026-06-30
2026-08-1413G/Ano. 1Steven Boydparent holding company, individual730K5.0%2026-06-30
2026-07-1513DMichael C. Skaffindividual2.8M19.9%2026-06-30
2026-07-1513DSP Manager LLCother entity2.8M19.9%2026-06-30
2026-07-1513DV-Co Investors 3 LLCother entity1.4M9.7%2026-06-30
2026-07-1513DV-Co Investors 2 LLCother entity828K5.9%2026-06-30
2026-07-1513DV-CO Investors LLCother entity514K3.7%2026-06-30
2026-07-1513DV-Co Investors 4 LLCother entity87K0.6%2026-06-30

What this page is

Vivos Therapeutics in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Vivos Therapeutics (VVOS), SEC CIK 1716166, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-23.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-30.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-09-03.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-04-15.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-07-31.JSON and CSV
Company record
EDGAR filing index for CIK 1716166Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of VVOS is sold short?
2,864,201 shares were held short at the 2026-09-30 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is VVOS's daily short volume?
On 2026-10-23, 77,544 of the 246,213 VVOS shares reported to FINRA were sold short, 31.5% of the day's reported volume. Short volume is a flow for one day, not a position.
Does VVOS have fails to deliver?
The SEC's latest file shows 570,147 VVOS shares failed to deliver at settlement 2026-09-30. Fails are reported per settlement date and published twice a month with a lag.
Are VVOS insiders buying or selling?
No open-market insider trades were reported for VVOS in the last 90 days. The most recent filings are listed below. Latest filing: Amman Bradford K. (Principal Accounting Officer) on 2026-07-31.
Who owns 5% or more of VVOS?
4 holders report 5% or more of VVOS in their latest filing, all on Schedule 13D (active intent). The largest reported stake is Michael C. Skaff at 19.9% of the class (2,783,102 shares), filed 2026-07-15 for an event on 2026-06-30.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.